Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination

The 3D structures of human therapeutic targets are enabling for drug discovery. However, their purification and crystallization remain rate determining. In individual cases, ligands have been used to increase the success rate of protein purification and crystallization, but the broad applicability of this approach is unknown. We implemented two screening platforms, based on either fluorimetry or static light scattering, to measure the increase in protein thermal stability upon binding of a ligand without the need to monitor enzyme activity. In total, 221 different proteins from humans and human parasites were screened against one or both of two sorts of small-molecule libraries. The first library comprised different salts, pH conditions, and commonly found small molecules and was applicable to all proteins. The second comprised compounds specific for protein families of particular interest (e.g., protein kinases). In 20 cases, including nine unique human protein kinases, a small molecule was identified that stabilized the proteins and promoted structure determination. The methods are cost-effective, can be implemented in any laboratory, promise to increase the success rates of purifying and crystallizing human proteins significantly, and identify new ligands for these proteins.

[1]  S. Knapp,et al.  Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase. , 2005, Journal of medicinal chemistry.

[2]  Daumantas Matulis,et al.  Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. , 2005, Biochemistry.

[3]  Jonathan Bard,et al.  Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. , 2004, Analytical biochemistry.

[4]  L. Abrahmsén,et al.  High-level production and optimization of monodispersity of 11beta-hydroxysteroid dehydrogenase type 1. , 2004, Biochimica et biophysica acta.

[5]  Lu-Yun Lian,et al.  A simple method for improving protein solubility and long-term stability. , 2004, Journal of the American Chemical Society.

[6]  B. Kurganov,et al.  Kinetics of Protein Aggregation. Quantitative Estimation of the Chaperone-Like Activity in Test-Systems Based on Suppression of Protein Aggregation , 2002, Biochemistry (Moscow).

[7]  Hans-Joachim Böhm,et al.  A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.

[8]  G. Bemis,et al.  Kinase inhibitors and the case for CH…O hydrogen bonds in protein–ligand binding , 2002, Proteins.

[9]  Victor S. Lobanov,et al.  High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery , 2001 .

[10]  K. P. Murphy,et al.  Stabilization of protein structure. , 2001, Methods in molecular biology.

[11]  Mark Gerstein,et al.  Structural proteomics of an archaeon , 2000, Nature Structural Biology.

[12]  P. Maček,et al.  pH and temperature-induced molten globule-like denatured states of equinatoxin II: a study by UV-melting, DSC, far- and near-UV CD spectroscopy, and ANS fluorescence. , 1997, Biochemistry.

[13]  K. Arai,et al.  Mechanism of dnaB protein action. I. Crystallization and properties of dnaB protein, an essential replication protein in Escherichia coli. , 1981, The Journal of biological chemistry.